Zurampic Offers a New Option for Gout

Roni Shye
Roni Shye, PharmD BCGP BCACP, is a licensed pharmacist in the states of Florida, Ohio, and Pennsylvania.
Posted on

Zurampic (lesinurad) is the newest medication to be approved by the FDA for the treatment of gout. Gout is an inflammatory type of arthritis that results from the buildup or uric acid crystals in the body.

Recent statistics from the CDC (Centers for Disease Control and Prenvention) show that gout is on the rise in the US, likely related to the rise in obesity in recent years.

What is Zurampic used for?
Zurampic is used with another type of gout medication called a xanthine oxidase inhibitor (some examples include allopurinol and febuxostat). Zurampic is added to your other treatment if your uric acid levels haven’t lowered enough with the xanthine oxidase inhibitor alone.

Basically, Zurampic is used to treat gout—but not by itself.

Is there anything unique about Zurampic?

Yes. Zurampic is the first of its type of medication—selective uric acid reabsorption inhibitor—to be approved in the United States.

How is Zurampic used?

The recommended dose of Zurampic is 200 mg taken once daily in the morning with food and water—and again, it must be used with another drug like allopurinol.

Zurampic will be available in a tablet in a 200 mg strength.

What are the side effects of Zurampic?

The most common side effects associated with Zurampic include headache, influenza, and gastroesophageal reflux disease (GERD).

When will Zurampic be available?

At this time the manufacturer, AstraZeneca, doesn’t have an estimate release date for Zurampic.

Want more information?

See the press release from the manufacturer here, and the announcement from the FDA here.

Drugs featured in this story

Filed under